Balfaxar receives FDA nod for treating acquired coagulation factor deficiency

Octapharma USA has announced the US Food and Drug Administration (FDA)'s approval of Balfaxar (prothrombin complex concentrate, human-lans), a treatment for urgent reversal of acquired ... Read More